Basics BioLife Solutions, Inc. BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation. IPO Date: October 1, 2002 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $1.01B Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 3.04% Avg Daily Range (30 D): $0.71 | 3.14% Avg Daily Range (90 D): $0.65 | 2.63% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): .46M Avg Daily Volume (90 D): .31M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 1,262 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.41M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $1.59M Avg Closing Trade (90 D): $1.42M Avg Closing Volume: 58.3K         News Mar 5, 2025 @ 8:30 AM Global Cryopreservation Freezers Market to Reach U... Source: Future Market Insights, Inc. Feb 20, 2025 @ 9:03 PM BioLife Solutions to Report Fourth Quarter and Ful... Source: Prnewswire Feb 12, 2025 @ 9:47 AM $536.73 Bn Organ Preservation Solution Market Stra... Source: Na Dec 16, 2024 @ 1:11 PM BioLife Solutions Appoints Tony J. Hunt to its Boa... Source: Prnewswire Dec 16, 2024 @ 11:00 AM Eyelash Serum Market to hit USD 1.29 billion by 20... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.04 $-.45 $-.22 Diluted EPS $-.04 $-.45 $-.22 Revenue $ 30.57M $ 28.33M $ 31.73M Gross Profit $ $ $ Net Income / Loss $ -1.7M $ -20.72M $ -10.22M Operating Income / Loss $ -1.56M $ -2.8M $ -10.13M Cost of Revenue $ $ $ Net Cash Flow $ 2.08M $ -7.68M $ -5.65M PE Ratio     Splits Jan 29, 2014:   14:1